Drug intelligence / Profile preview

Win-Max

Development stage
Unknown
Modality
Small Molecules
Administration
Intramuscular, Intravenous
01

Overview

Win-Max is a veterinary pharmaceutical product, specifically a combination injectable solution used in livestock and companion animals. It typically contains a combination of an antibiotic (often oxytetracycline) and a non-steroidal anti-inflammatory drug (NSAID, such as flunixin meglumine). This combination is designed to provide simultaneous antimicrobial activity against susceptible pathogens and anti-inflammatory, analgesic, and anti-pyretic effects to manage pain and fever associated with respiratory infections or other inflammatory conditions. The antibiotic component inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit, while the NSAID component inhibits cyclooxygenase (COX) enzymes, thereby reducing prostaglandin synthesis.

Brand names
Win-Max
02

Targets

PGHS-1 (Prostaglandin G/H Synthase 1)Bacterial RibosomePTGS2 (Prostaglandin-Endoperoxide Synthase 2)

Beyond the preview

Go deeper on Win-Max.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Win-Max.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call